These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 28363207)
1. A commentary on the new ESC guidelines on dyslipidaemias. Drexel H Eur Heart J Cardiovasc Pharmacother; 2017 Apr; 3(2):73-74. PubMed ID: 28363207 [No Abstract] [Full Text] [Related]
2. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). ; Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Perrone Filardi P; Riccardi G; Storey RF; Wood D; Atherosclerosis; 2011 Jul; 217 Suppl 1():S1-44. PubMed ID: 21723445 [No Abstract] [Full Text] [Related]
3. New ESC/EAS Guidelines for the management of dyslipidaemias - any controversies behind the consensus? Reiner Z Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):724-7. PubMed ID: 21945917 [No Abstract] [Full Text] [Related]
4. The new joint EAS/ESC guidelines for the management of dyslipidaemias. Catapano AL; Chapman J; Wiklund O; Taskinen MR Atherosclerosis; 2011 Jul; 217(1):1. PubMed ID: 21722901 [No Abstract] [Full Text] [Related]
5. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman M; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D; ; Atherosclerosis; 2011 Jul; 217(1):3-46. PubMed ID: 21882396 [No Abstract] [Full Text] [Related]
6. [2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: What is new?]. Kayıkçıoğlu M; Tokgözoğlu L Turk Kardiyol Dern Ars; 2017 Mar; 45(2):109-112. PubMed ID: 28424431 [No Abstract] [Full Text] [Related]
7. [A perspective to lipid lowering therapy after ESC/EAS guidelines for the management of dyslipidaemias and the European guidelines on cardiovascular disease prevention in clinical practice]. Ural D Turk Kardiyol Dern Ars; 2012 Jun; 40(4):293-7. PubMed ID: 22951844 [No Abstract] [Full Text] [Related]
8. [2016 ESC/EAS Guidelines for the Management of Dyslipidaemias]. Catapano AL; Graham I; De Backer G; Wiklund O; Chapman MJ; Drexel H; Hoes AW; Jennings CS; Landmesser U; Pedersen TR; Reiner Ž; Riccardi G; Taskinen MR; Tokgozoglu L; Verschuren WM; Vlachopoulos C; Wood DA; Zamorano JL Kardiol Pol; 2016; 74(11):1234-1318. PubMed ID: 27910077 [No Abstract] [Full Text] [Related]
10. [The new 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk: comparison with the ESC/EAS recommendations for the management of dyslipidemias]. Catapano AL; Averna M; Faggiano P; Novo S G Ital Cardiol (Rome); 2014 Jan; 15(1):19-20. PubMed ID: 24503730 [No Abstract] [Full Text] [Related]
11. Dyslipidaemias: new mechanistic insights and the 2016 ESC Guidelines. Lüscher TF Eur Heart J; 2016 Oct; 37(39):2963-2965. PubMed ID: 27923852 [No Abstract] [Full Text] [Related]
12. Summary of 2016 ESC guidelines on heart failure, atrial fibrillation, dyslipidaemia and cardiovascular prevention. Claeys MJ; Mullens W; Vandekerckhove Y; Duytschaever M; De Maeyer C; Pasquet A Acta Cardiol; 2017 Dec; 72(6):610-615. PubMed ID: 28685644 [TBL] [Abstract][Full Text] [Related]
13. 'Ten Commandments' from the 2016 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J; 2016 Oct; 37(39):2966. PubMed ID: 27923853 [No Abstract] [Full Text] [Related]
14. Similarities and differences between European and United States guidelines for the management of dyslipidaemias. Reiner Ž Kardiol Pol; 2015; 73(7):471-7. PubMed ID: 26189467 [No Abstract] [Full Text] [Related]
15. Comments on the 2016 ESC/EAS Guidelines for the Management of Dyslipidemias. Pérez de Isla L; ; Pérez de Isla L; Fernández PLS; Álvarez-Sala Walther L; Barrios Alonso V; Castro Conde A; Galve Basilio E; García Ortiz L; Mata López P; ; Alegría Ezquerra E; Cordero Fort A; Cosin Sales J; Escobar Cervantes C; García-Moll Marimón X; José Gómez Doblas J; Marzal Martín D; Murga Eizagaechevarria N; de Pablo Zarzosa C; Miguel Rincón L; Sanchis Forés J; ; Alberto San Román Calvar J; Alfonso Manterola F; Arribas Ynsaurriaga F; Evangelista Masip A; Ferreira González I; Jiménez Navarro M; Marín Ortuño F; Pérez de Isla L; Rodríguez Padial L; Luis Sánchez Fernández P; Sionis Green A; Vázquez García R Rev Esp Cardiol (Engl Ed); 2017 Feb; 70(2):72-77. PubMed ID: 28131410 [No Abstract] [Full Text] [Related]
16. Do we need a redefinition of the cardiovascular risk categories used in the 2019 ESC/EAS guidelines on dyslipidaemias? Gragnano F; Calabrò P Eur Heart J; 2020 Jun; 41(24):2332. PubMed ID: 32031600 [No Abstract] [Full Text] [Related]
20. The first European Guidelines focussed on: management of dyslipidaemias. Taylor J Eur Heart J; 2011 Aug; 32(16):1949-50. PubMed ID: 21841204 [No Abstract] [Full Text] [Related] [Next] [New Search]